Establishment Labs Holdings Inc (ESTA) Stock Analysis
Breakout setup
Healthcare · Medical Devices
Sell if holding. Engine safety override at $83.25: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 16%; Below-average business quality; Rich valuation.
Establishment Labs develops and commercializes Motiva silicone gel-filled breast implants for augmentation and reconstruction, registered in 100+ countries including the U.S. (FDA PMA approved September 2024). Revenue is predominantly from Motiva Implant sales; newer products... Read more
Sell if holding. Engine safety override at $83.25: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 16%; Below-average business quality; Rich valuation. Chart setup: Golden cross, above all MAs, RSI 66, MACD bullish. Score 5.3/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 52d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-15Recent Developments — Establishment Labs Holdings Inc
Latest news
- NEWS BTIG Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $90 — benzinga May 7, 2026 positive
- NEWS Earnings Scheduled For May 6, 2026 — benzinga May 6, 2026 neutral
- NEWS 10 Health Care Stocks Whale Activity In Today's Session — benzinga May 6, 2026 neutral
- NEWS Establishment Labs Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript — benzinga May 6, 2026 neutral
- NEWS Establishment Labs Hldgs Raises FY2026 Sales Guidance from $264.000M-$266.000M to $266.500M-$268.500M vs $264.984M Est — benzinga May 6, 2026 positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSuppliersingle-source medical-grade silicone supplier10-K Item 1A: 'We rely on a single-source, third-party supplier for medical-grade long-term implantable silicone, which is the primary raw material used in our Motiva Implants.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers·1 ceiling hit
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Volatile — 5.9% daily ATR makes tight stops impractical. Position-size conservatively.static
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $83.25: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 16%; Below-average business quality; Rich valuation. Chart setup: Golden cross, above all MAs, RSI 66, MACD bullish. Prior stop was $77.42. Score 5.3/10, moderate confidence.
Take-profit target: $84.28 (+1.2% upside). Prior stop was $77.42. Stop-loss: $77.42.
Concentration risk — Supplier: single-source medical-grade silicone supplier; Target reached (-5.8% upside); Risk below floor (2.8 < 3.0).
Establishment Labs Holdings Inc trades at a P/E of N/A (forward 1095.2). TrendMatrix value score: 3.6/10. Verdict: Sell.
15 analysts cover ESTA with a consensus score of 4.2/5. Average price target: $90.
What does Establishment Labs Holdings Inc do?Establishment Labs develops and commercializes Motiva silicone gel-filled breast implants for augmentation and...
Establishment Labs develops and commercializes Motiva silicone gel-filled breast implants for augmentation and reconstruction, registered in 100+ countries including the U.S. (FDA PMA approved September 2024). Revenue is predominantly from Motiva Implant sales; newer products include Mia Femtech (minimally invasive augmentation) and Preservé.